Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Anti-TNF therapy can cause hair loss and skin issues.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

New therapies for rare skin diseases show promise but need more research.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

People with certain skin disorders are more likely to have alcohol problems, especially if they also have mental health issues like depression and anxiety.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Cannabinoids like CBD may help treat skin diseases by reducing inflammation and infections.

Certain plants like Aloe vera and Neem are effective and safe for treating various skin conditions.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Improving education, training, and access to affordable treatments is crucial for better managing inflammatory skin diseases in Latin America.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

Cell adhesion molecules are important in the development of certain skin diseases.

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.